Literature DB >> 19118376

Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma.

Marylène Lejeune1, Tomás Alvaro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19118376      PMCID： PMC2625413          DOI： 10.3324/haematol.2008.001255

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  26 in total

Review 1.  Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

Authors:  Daphne de Jong
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

2.  CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Authors:  Björn Engelbrekt Wahlin; Birgitta Sander; Birger Christensson; Eva Kimby
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 3.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

4.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

Authors:  Tomás Alvaro; Marylène Lejeune; Francisca I Camacho; Ma Teresa Salvadó; Lydia Sánchez; Juan F García; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons; Carmen Bellas; Miguel A Piris
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

5.  High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

Authors:  Joaquim Carreras; Armando Lopez-Guillermo; Bridget C Fox; Lluis Colomo; Antonio Martinez; Giovanna Roncador; Emili Montserrat; Elias Campo; Alison H Banham
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

6.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

7.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Authors:  Pedro Farinha; Hamid Masoudi; Brian F Skinnider; Karey Shumansky; John J Spinelli; Karamjit Gill; Richard Klasa; Nicolas Voss; Joseph M Connors; Randy D Gascoyne
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

8.  Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.

Authors:  Abigail M Lee; Andrew J Clear; Maria Calaminici; Andrew J Davies; Suzanne Jordan; Finlay MacDougall; Janet Matthews; Andrew J Norton; John G Gribben; T Andrew Lister; Lindsey K Goff
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

9.  Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Authors:  Tomás Alvaro; Marylène Lejeune; Maria-Teresa Salvadó; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

10.  Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.

Authors:  Erika A Danna; Pratima Sinha; Mileka Gilbert; Virginia K Clements; Beth A Pulaski; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701
View more
  4 in total

1.  Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.

Authors:  Martin Wartenberg; Peter Vasil; Christian Meyer zum Bueschenfelde; German Ott; Andreas Rosenwald; Falko Fend; Marcus Kremer
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 2.  Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.

Authors:  Tomás Alvaro; Luis de la Cruz-Merino; Fernando Henao-Carrasco; José Luis Villar Rodríguez; David Vicente Baz; Manuel Codes Manuel de Villena; Mariano Provencio
Journal:  J Biomed Biotechnol       Date:  2010-08-12

3.  A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior.

Authors:  Ezequiel Monferrer; Susana Martín-Vañó; Aitor Carretero; Andrea García-Lizarribar; Rebeca Burgos-Panadero; Samuel Navarro; Josep Samitier; Rosa Noguera
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

4.  Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models.

Authors:  Ezequiel Monferrer; Sabina Sanegre; Susana Martín-Vañó; Andrea García-Lizarribar; Rebeca Burgos-Panadero; Amparo López-Carrasco; Samuel Navarro; Josep Samitier; Rosa Noguera
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.